2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction
FM Kusumoto, MH Schoenfeld, BL Wilkoff… - Heart …, 2017 - heartrhythmjournal.com
From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of …
Authors/Task Force Members, SG Priori… - Ep …, 2015 - academic.oup.com
The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …
European Heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections …
C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020 - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …
PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the …
P Khairy, GF Van Hare, S Balaji, CI Berul… - Heart …, 2014 - heartrhythmjournal.com
4. Delivery of care and ensuring access to care.............. e108 4.1. Recommendations for the
coordination and delivery of care for adults with CHD and arrhythmias …
coordination and delivery of care for adults with CHD and arrhythmias …
Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital …
A Hernandez-Madrid, T Paul, D Abrams, PF Aziz… - EP …, 2018 - academic.oup.com
The population of patients with congenital heart disease (CHD) is continuously increasing
with more and more patients reaching adulthood. A significant portion of these young adults …
with more and more patients reaching adulthood. A significant portion of these young adults …
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Developed in …
MJ Shah, MJ Silka, JNA Silva, S Balaji… - Cardiology in the …, 2021 - cambridge.org
In view of the increasing complexity of both cardiovascular implantable electronic devices
(CIEDs) and patients in the current era, practice guidelines, by necessity, have become …
(CIEDs) and patients in the current era, practice guidelines, by necessity, have become …
Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association
KK Stout, CS Broberg, WM Book, F Cecchin, JM Chen… - Circulation, 2016 - Am Heart Assoc
The past 60 years have brought remarkable advancements in the diagnosis and treatment of
congenital heart disease (CHD). Early diagnosis and improvements in cardiac surgery and …
congenital heart disease (CHD). Early diagnosis and improvements in cardiac surgery and …
Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)
Importance Sudden cardiac death (SCD) is the most common mode of death in childhood
hypertrophic cardiomyopathy (HCM), but there is no validated algorithm to identify those at …
hypertrophic cardiomyopathy (HCM), but there is no validated algorithm to identify those at …
[HTML][HTML] 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients …
WC Members, MJ Shah, MJ Silka, JNA Silva… - JACC: Clinical …, 2021 - Elsevier
In view of the increasing complexity of both cardiovascular implantable electronic devices
(CIEDs) and patients in the current era, practice guidelines, by necessity, have become …
(CIEDs) and patients in the current era, practice guidelines, by necessity, have become …
Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review
TM Roston, K Jones, NM Hawkins, JM Bos… - Heart Rhythm, 2018 - Elsevier
Background The implantable cardioverter-defibrillator (ICD) may be associated with a high
risk of complications in patients with catecholaminergic polymorphic ventricular tachycardia …
risk of complications in patients with catecholaminergic polymorphic ventricular tachycardia …